Literature DB >> 20842033

Tissue engineering for treatment of vocal fold scar.

Jennifer L Long1.   

Abstract

PURPOSE OF REVIEW: Creating a neovocal fold or lamina propria by tissue engineering is a potential scheme for treating severe vocal fold scar. Although still investigational, multiple approaches have recently been described in tissue culture or animal models. RECENT
FINDINGS: Proposed cell types for vocal fold application have been native vocal fold fibroblasts, autologous fibroblasts from nonlaryngeal tissues, and adult-derived stem cells. Scaffolds of interest include decellularized matrix, biological polymers, and synthetic or chemically modified biopolymers. Chemical, mechanical, and spatial signals have been applied, such as hepatocyte growth factor, cyclic stretch, and air interface. Cells, matrix, and signals are combined in an effort to replicate normal vocal fold tissue as closely as possible. Each of these components of vocal fold tissue engineering is discussed here.
SUMMARY: Multiple tissue engineering approaches hold promise for reproducing functional vocal fold tissue. Scar prevention techniques have been the most successful. Modifying existing scar is more difficult and may necessitate complete scar excision and replacement with a three-dimensional neotissue. Functional assessment in vivo is essential to the ongoing evaluation of techniques.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842033     DOI: 10.1097/MOO.0b013e32833febf2

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  9 in total

1.  Effects of vocal fold epithelium removal on vibration in an excised human larynx model.

Authors:  Justin R Tse; Zhaoyan Zhang; Jennifer L Long
Journal:  J Acoust Soc Am       Date:  2015-07       Impact factor: 1.840

2.  Porcine Vocal Fold Lamina Propria-Derived Biomaterials Modulate TGF-β1-Mediated Fibroblast Activation in Vitro.

Authors:  Camilo Mora-Navarro; Andreea Badileanu; Ana M Gracioso Martins; Emily W Ozpinar; Lewis Gaffney; Ian Huntress; Erin Harrell; Jeffrey R Enders; Xinxia Peng; Ryan C Branski; Donald O Freytes
Journal:  ACS Biomater Sci Eng       Date:  2020-02-11

3.  MERS versus Standard Surgical Approaches for Porcine Vocal Fold Scarring with Adipose Stem Cell Constructs.

Authors:  Joo Hyun Woo; Suzanne N King; Henry Hoffman; Seth Dailey; Sarah Wang; Michael B Christensen; Susan L Thibeault
Journal:  Otolaryngol Head Neck Surg       Date:  2016-05-10       Impact factor: 3.497

Review 4.  Apoptosis and Vocal Fold Disease: Clinically Relevant Implications of Epithelial Cell Death.

Authors:  Carolyn K Novaleski; Bruce D Carter; M Preeti Sivasankar; Sheila H Ridner; Mary S Dietrich; Bernard Rousseau
Journal:  J Speech Lang Hear Res       Date:  2017-05-24       Impact factor: 2.297

5.  A rabbit vocal fold laser scarring model for testing lamina propria tissue-engineering therapies.

Authors:  Ted Mau; Mindy Du; Chet C Xu
Journal:  Laryngoscope       Date:  2014-06-03       Impact factor: 3.325

6.  Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks.

Authors:  Xian Xu; Amit K Jha; Daniel A Harrington; Mary C Farach-Carson; Xinqiao Jia
Journal:  Soft Matter       Date:  2012       Impact factor: 3.679

7.  Biocompatibility and Viscoelastic Properties of Injectable Resilin-Like Polypeptide and Hyaluronan Hybrid Hydrogels in Rabbit Vocal Folds.

Authors:  Renee E King; Hang Kuen Lau; Haiyan Zhang; Ishnoor Sidhu; Michael B Christensen; Eric W Fowler; Linqing Li; Xinqiao Jia; Kristi L Kiick; Susan L Thibeault
Journal:  Regen Eng Transl Med       Date:  2019-02-27

8.  Hyaluronic Acid/Alginate Hydrogel Containing Hepatocyte Growth Factor and Promotion of Vocal Fold Wound Healing.

Authors:  Jeong-Seok Choi; Se Heang Oh; Young-Mo Kim; Jae-Yol Lim
Journal:  Tissue Eng Regen Med       Date:  2020-07-16       Impact factor: 4.169

9.  Potassium titanyl phosphate laser-induced inflammatory response and extracellular matrix turnover in rabbit vocal fold scar.

Authors:  Jing Zhang; Ruiqing Zhen; Chunsheng Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-02       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.